Adiponectin suppresses inflammatory responses at the early phase of atherosclerosis in hyperglycemic rats

Molecular Medicine Reports

Volumn 3, Issue 2, 2010, Pages 323-328

  Liu, Jin Bo ^a,b   Jia, Lin ^a   Li, Bing Rong ^b   Lan, Li Zhen ^b   Ge, Qian ^b   Zheng, Hong Ting ^b   Deng, Hua Cong ^b  

^a SHANDONG UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Atherosclerosis; Hyperglycemia; Inflammation

Indexed keywords

ADENOVIRUS VECTOR; ADIPONECTIN; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; DRUG INDUCED DISEASE; GENE EXPRESSION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HYPERGLYCEMIA; INFLAMMATION; MALE; METABOLIC PARAMETERS; NONHUMAN; PROTEIN BLOOD LEVEL; RAT;

ADENOVIRIDAE; RATTUS;

EID: 77950842893     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_000000260     Document Type: Article

References (21)

1. 1.Cavusoglu E, Ruwende C, Chopra V, et al: Adiponectin is an independent predictor of all-cause mortality, cardiac mortality and myocardial infarction in patients presenting with chest pain. Eur Heart J 27: 2300-2309, 2006.
2. Koenig W, Khuseyinova N, Baumert J, Meisinger C and Lowel H: Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J Am Coll Cardiol 48: 1369-1377, 2006.
3. Iwashima Y, Horio T, Suzuki Y, et al: Adiponectin and inflammatory markers in peripheral arterial occlusive disease. Atherosclerosis 188: 384-390, 2006.
4. Yaturu S, Bridges JF and Subba Reddy DR : Decreased levels of plasma adiponectin in prediabetes, type 2 diabetes and coronary artery disease. Med Sci Monit 12: CR 17-CR 20, 2006. (Pubitemid 43116654)
5. Ouchi N, Kihara S, Arita Y, et al: Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102: 1296-1301, 2000.
6. Okamoto Y, Kihara S, Ouchi N, et al: Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 106: 2767-2770, 2002.
7. Weyer C, Funahashi T, Tanaka S, et al: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935, 2001.
8. Dzielinska Z, Januszewicz A, Wiecek A, et al: Decreased plasma concentration of a novel anti-inflammatory protein - adiponectin - in hypertensive men with coronary artery disease. Thromb Res 110: 365-369, 2003.
9. Kawano T, Saito T, Yasu T, et al: Close association of hypoadiponectinemia with arteriosclerosis obliterans and ischemic heart disease. Metabolism 54: 653-656, 2005.
10. Shetty GK, Economides PA, Horton ES, Mantzoros CS and Veves A: Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27: 2450-2457, 2004.
11. Yuan G, Zhou L, Tang J, et al: Serum CR P levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity. Diabetes Res Clin Pract 72: 244-250, 2006.
12. Mojiminiyi OA , Abdella NA , Al Arouj M and Ben Nakhi A: Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with type 2 diabetes. Int J Obes 31: 213-220, 2007.
13. Dullaart RP, De Vries R, Sluiter WJ and Voorbij HA: High plasma C-reactive protein is related to low paraoxonase-I activity independently of high leptin and low adiponectin in type 2 diabetes mellitus. Clin Endocrinol 70: 221-226, 2008.
14. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126, 1999.
15. 15.Cybulsky MI and Gimbrone MA Jr: Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251: 788-791, 1991.
16. Kranzhofer R, Schmidt J, Pfeiffer CA , Hagl S, Libby P and Kubler W: Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 19: 1623-1629, 1999. (Pubitemid 29323820)
17. Verma S, Wang CH, Li SH, et al: A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 106: 913-919, 2002.
18. Matsuda M, Shimomura I, Sata M, et al: Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 277: 37487-37491, 2002.
19. Teoh H, Quan A, Bang KW, et al: Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. Am J Physiol Endocrinol Metab 295: E658-E664, 2008.
20. Devaraj S, Torok N, Dasu MR, Samols D and Jialal I: Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Arterioscler Thromb Vasc Biol 28: 1368-1374, 2008.
21. Li CJ, Sun HW, Zhu FL, et al: Local adiponectin treatment reduces atherosclerotic plaque size in rabbits. J Endocrinol 193: 137-145, 2007.